Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia Accessibility StatementSkip Navigation Expansion into Bangladesh, Pakistan, Nepal, and Sri Lanka increases TAM in region to $13 billion and supports commercialization strategy for the PCR Pro® and SARAGENE® product line SALT LAKE CITY, March 20, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for th ...